Reduced prices of 1,364 cancer drugs take effect, big relief for patients
The reduction in the maximum retail price of 1,364 cancer treatment drugs by the central government came into effect on Monday. This step will save patients across the country approximately Rs 3,540 crore annually.
The central government has taken a major step aimed at reducing the cost of medicines for cancer patients. The reduced prices of 1,364 anti-cancer drugs under 121 salts determined by the National Pharmaceutical Pricing Authority have come into force across the country from Monday.
According to the Ministry of Chemicals and Fertilizers, the implementation of the new rates will save consumers an estimated Rs 3,540.38 crore every year. A cap has been placed on commercial profits to reduce the financial burden on patients and their families during cancer treatment.
The ministry has informed that by November 8, 85 pharmaceutical companies have released revised prices for 1,364 formulations. Out of these, prices of 679 brands have dropped by more than 50 percent, while the rates of some medicines have decreased by up to 96.45 percent.
The authority has instructed that no chemist or hospital pharmacy can charge more than the printed new rates for these medicines. Patients can also verify the new price printed on the medicine packet through the Pharma Sahi Daam mobile app or the authority's website.
If any seller demands more than the prescribed price, consumers can lodge a complaint on the Pharma Jan Samadhan portal. In addition, direct contact can also be made on the toll-free helpline number 1800-111-255.
Key developments
- Revised retail rates of 1,364 cancer drugs implemented from Monday
- Prices of 679 brands dropped by more than 50 percent, maximum cut remained 96.45 percent
- New rates will save patients across the country around Rs 3,540 crore annually
- Strict instruction to chemists and hospitals not to charge more than the new rates
